Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion
2020; Elsevier BV; Volume: 136; Issue: 6 Linguagem: Inglês
10.1182/blood.2020007079
ISSN1528-0020
AutoresXinyi Xia, Kening Li, Lingxiang Wu, Zhihua Wang, Mengyan Zhu, Bin Huang, Jie Li, Ziyu Wang, Wei Wu, Min Wu, Wanlin Li, Li Lu, Yun Cai, Bakwatanisa Bosco, Aifang Zhong, Xiong Liu, Tangfeng Lv, Zhenhua Gan, Guang Chen, Yunhu Pan, Caidong Liu, Kai Zhang, Xiaoli Xu, Changjun Wang, Qianghu Wang,
Tópico(s)SARS-CoV-2 and COVID-19 Research
ResumoTwo case series examining the impact of convalescent plasma on patients with COVID-19 suggest some clinical benefit from early administration and modest impact on parameters of inflammation. Further assessment of the impact of this intervention awaits controlled clinical trials.
Referência(s)